Symphony Neuro Development Company was a collaboration with Guilford Pharmaceuticals Inc. Symphony Neuro was subsequently acquired by GliaMed, Inc.
Symphony Evolution, Inc. was a collaboration with Exelixis, Inc. Symphony Evolution currently owns full rights to XL647, XL784 and XL999.
Symphony GenIsis, Inc. was a collaboration with Isis Pharmaceuticals, Inc. Symphony GenIsis was acquired by Isis in September 2007.
Symphony Allegro, Inc. was a collaboration with Alexza Pharmaceuticals, Inc. Symphony Allegro was acquired by Alexza in August 2009.
Symphony ViDA, Inc. was a collaboration with OXiGENE, Inc. Symphony ViDA was acquired by OXiGENE in July 2009.
|
